Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
147.50    -1.50 (-1.01%)
Bid:
145.00
Ask:
150.00
Spread: 5.00 (3.448%)
Market Cap: £45.56m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Director/PDMR Shareholding - Amendment

13 Dec 2017 16:58

RNS Number : 2856Z
Gattaca PLC
13 December 2017
 

The following amendment has been made to the 'Director / PDMR Shareholding' announcement released on 12 December 2017 at 07:00 under RNS No 0201Z.

Paragraph three of the original announcement incorrectly referred to Mr Wilkinson's shareholding increasing to 1.46%; this is now corrected to refer to Mr Lewis.

All other details remain unchanged.

The full amended text is shown below.

 

 

13 December 2017

 

 

Gattaca plc (the 'Company')

Director / PDMR Shareholding

 

The Company announces that today:

Chief Executive Officer, Brian Wilkinson, exercised nil-cost options to acquire 7,450 ordinary shares of 1 pence each in the Company, such options having previously vested under the Company's 2011 Value Creation Plan ("VCP"). Mr Wilkinson's total interest in the Company increases to 183,701 shares being 0.58% of the Company's issued share capital;

Chief Operating Officer, Keith Lewis, exercised nil-cost options to acquire 73,286 ordinary shares of 1 pence each in the Company, such options having previously vested under the Company's 2011 Value Creation Plan ("VCP"). Mr Lewis' total interest in the Company increases to 465,169 shares being 1.46% of the Company's issued share capital;

The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further details of the transaction on 7 December 2017.

 

For further information please contact:

Gattaca plc

+44 (0) 1489 898989

Brian Wilkinson, Chief Executive Officer

Salar Farzad, Chief Financial Officer

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Louise Mason-Rutherford / Nick Hayns

 

Numis Securities Limited

+44 (0) 20 7260 1000

Michael Meade / Tom Ballard

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Brian Wilkinson

2.

Reason for the notification

a)

Position/status: Chief Executive Officer

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Gattaca plc

b)

LEI: 213800LM81ZQ9V9G6866

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 1p each.

Identification code: GB00B1FMDQ43

b)

Nature of the transaction: Exercise of nil-cost option to acquire ordinary shares of 1p each under the Company's 2011 Value Creation Plan.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

Nil cost

7,450

d)

Aggregated information:

· Aggregated volume: 7,450

· Price: Nil cost

e)

Date of the transaction: 2017/12/07

f)

Place of the transaction: XLON

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Keith Lewis

2.

Reason for the notification

a)

Position/status: Chief Operating Officer

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Gattaca plc

b)

LEI: 213800LM81ZQ9V9G6866

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 1p each.

Identification code: GB00B1FMDQ43

b)

Nature of the transaction: Exercise of nil-cost option to acquire ordinary shares of 1p each under the Company's 2011 Value Creation Plan.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

Nil cost

73,286

d)

Aggregated information:

· Aggregated volume: 73,286

· Price: Nil cost

e)

Date of the transaction: 2017/12/07

f)

Place of the transaction: XLON

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAKADFSLXFFF
Date   Source Headline
15th Feb 20237:00 amRNSTrading Statement
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
14th Dec 20223:02 pmRNSIssue of Ordinary Shares & Total Voting Rights
6th Dec 20221:55 pmRNSDirector/PDMR Shareholding
6th Dec 202212:55 pmRNSResult of AGM
3rd Nov 20227:00 amRNSPreliminary Results for the year ended 31 July 22
3rd Oct 202211:03 amRNSBlock Listing Six Monthly Return
29th Sep 20224:54 pmRNSEBT Share Purchase Programme
17th Aug 20227:00 amRNSTrading Update
8th Jul 202211:05 amRNSSecond Price Monitoring Extn
8th Jul 202211:00 amRNSPrice Monitoring Extension
8th Jul 20229:06 amRNSSecond Price Monitoring Extn
8th Jul 20229:00 amRNSPrice Monitoring Extension
6th May 202211:55 amRNSDirector/PDMR Shareholding
4th Apr 20224:20 pmRNSConfirmation of Director Appointment
1st Apr 20229:35 amRNSBlock listing six monthly return
31st Mar 20227:00 amRNSInterim Results
15th Mar 20227:00 amRNSBoard Succession
18th Jan 20229:05 amRNSSecond Price Monitoring Extn
18th Jan 20229:00 amRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSTrading Update
16th Dec 20211:40 pmRNSDirector/PDMR Shareholding
8th Dec 20214:14 pmRNSResult of AGM
8th Dec 20214:10 pmRNSDirectorate Change
2nd Dec 202111:06 amRNSSecond Price Monitoring Extn
2nd Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20219:05 amRNSSecond Price Monitoring Extn
4th Nov 20219:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSPreliminary Results for the year ended 31 July 21
1st Oct 20219:09 amRNSBlock Listing Six Monthly Return
20th Sep 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSTrading Update
13th Jul 202110:50 amRNSDirector/PDMR Shareholding
17th Jun 202112:01 pmRNSDirector/PDMR Shareholding
10th Jun 20214:20 pmRNSDirector/PDMR Shareholding
8th Jun 202111:00 amRNSPrice Monitoring Extension
26th May 20214:40 pmRNSSecond Price Monitoring Extn
26th May 20214:35 pmRNSPrice Monitoring Extension
21st May 20215:28 pmRNSDirector/PDMR Shareholding
21st May 202111:58 amRNSHolding(s) in Company
21st May 20217:00 amRNSTrading Update - Improved Outlook
14th May 202111:37 amRNSHolding(s) in Company
13th May 20211:24 pmRNSHolding(s) in Company
11th May 202111:34 amRNSHolding(s) in Company
23rd Apr 20212:53 pmRNSHolding(s) in Company
1st Apr 20219:29 amRNSBlock Listing Six Monthly Return
31st Mar 20217:00 amRNSInterim Results for the six months ended 31 Jan 21
17th Feb 20217:00 amRNSTrading Update
8th Dec 20201:05 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.